HomeBIOA • NASDAQ
BIOAGE Labs Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.36M | 86.54% |
Net income | -21.13M | -0.82% |
Net profit margin | — | — |
Earnings per share | -1.75 | — |
EBITDA | -25.32M | -86.76% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 354.35M | 1,537.17% |
Total assets | 358.23M | 1,281.86% |
Total liabilities | 35.11M | -47.29% |
Total equity | 323.13M | — |
Shares outstanding | 35.85M | — |
Price to book | 0.37 | — |
Return on assets | -18.23% | — |
Return on capital | -19.34% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -21.13M | -0.82% |
Cash from operations | -5.14M | 39.57% |
Cash from investing | -26.00K | — |
Cash from financing | 24.90M | 2,567.99% |
Net change in cash | 19.88M | 307.53% |
Free cash flow | -5.30M | — |
Previous close
$3.29
Day range
$3.03 - $3.40
Year range
$3.03 - $26.62
Market cap
115.20M USD
Avg Volume
206.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
63